Skip to main content

Venus Concept Inc.

VERODelisted Jan 30, 2026
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001409269

Venus Concept Inc. was delisted on Jan 30, 2026; its insiders filed their last Form 4 on Mar 30, 2026; 9 institutions reported holding it in 13F filings for Q4 2025, worth $189.5K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Venus Concept Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Venus Concept Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Venus Concept Inc.
NameTitleLast reported holdingLast filingFilings, past year
Madryn Health Partners, LP10% Owner37,547,373IndirectMar 30, 20261
Madryn Asset Management, LP10% Owner37,547,373IndirectMar 30, 20262
Madryn Health Advisors, LP10% Owner37,547,373IndirectMar 30, 20262
Madryn Health Partners (Cayman Master), LP10% Owner37,547,373IndirectMar 30, 20262
EW Healthcare Partners, L.P.10% Owner, Other: See footnotes 3, 5, 7 and 816,337,856IndirectMar 27, 20261
Essex Woodlands Fund IX-GP, L.P.10% Owner, Other: See footnotes 3, 5, 7 and 816,337,856IndirectMar 27, 20261
Essex Woodlands IX, LLC10% Owner, Other: See footnotes 3, 5, 7 and 816,337,856IndirectMar 27, 20261
EW Healthcare Partners-A, L.P.10% Owner, Other: See footnotes 3, 5, 7 and 816,337,856IndirectMar 27, 20261
Natale AnthonyDirector0IndirectDec 4, 20240
Masters Michael Willingham10% Owner209,803IndirectOct 7, 20240
Marlin Fund, Limited Partnership10% Owner383,345IndirectJun 12, 20240
Masters Capital Management LLC10% Owner383,345IndirectJun 12, 20240
Marlin Fund II, Limited Partnership10% Owner383,345IndirectJun 12, 20240
Marlin Fund III, Limited Partnership10% Owner383,345IndirectJun 12, 20240
MSS VC SPV LP10% Owner383,345IndirectJun 12, 20240
Masters Special Situations, LLC10% Owner383,345IndirectJun 12, 20240
Marlin Master Fund Offshore II, LP10% Owner383,345IndirectJun 12, 20240
Mandarello MichaelGeneral Counsel & Secretary1,491Aug 15, 20230
McGrail William HSr. VP7,783Mar 28, 20230
Barry Richard ScottDirector16,337,856IndirectMar 28, 20230
Sullivan Keith JDirector80,000IndirectMar 28, 20230
LaPorte Fritz LDirector–Mar 28, 20230
Kong GarhengDirector6,795,621IndirectMar 28, 20230
Georgiadis AnnaChief HR Officer12,877Mar 28, 20230
Della Penna DomenicExec VP & General Manager151,385Mar 28, 20230
Lacchin LouiseDirector–Mar 28, 20230
Portaro RossExec VP & General Manager133,966Mar 28, 20230
Hollmig Stanley TylerDirector290,000Mar 28, 20230
Sinay Soren MaorCOO–Feb 7, 20230
Serafino DomenicFormer Chief Executive Officer1,008,758Feb 7, 20230
Iger YoniVP, RA/QA/Clinical Affairs5,181Feb 7, 20230
Kotler AnatInterim VP, Global Marketing–Feb 7, 20230
Shimizu KenjiInterim CTO–Nov 29, 20220
Varghese Hemanth JacobPresident/Chief Bus. Officer250,000Nov 22, 20220
De Silva RajivOfficer1,250,000Nov 22, 20220
HealthQuest Venture Management II, L.L.C.10% Owner6,795,621Nov 22, 20220
HealthQuest Partners II, L.P.10% Owner6,795,621Nov 22, 20220
Saudi Economic & Development Securities Co10% Owner922,456IndirectJul 13, 20210
SEDCO Capital Cayman Ltd10% Owner922,456IndirectJul 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 6, 2021 (view filing)7:35 PM ETJul 1-25 daysSaudi Economic & Development Securities Co and 1 other10% OwnerSSale−46.3K$3.20−$148.2K−3.9%1.13M after4 lots
Jul 12, 2021 (view filing)10:05 AM ETJul 84 daysSaudi Economic & Development Securities Co and 1 other10% OwnerSSale−100.0K$3.20−$320.3K−8.8%1.03M after4 lots
Jul 12, 2021 (view filing)8:35 PM ETJul 93 daysSaudi Economic & Development Securities Co and 1 other10% OwnerSSale−57.9K$3.25−$188.3K−5.6%972.5K after2 lots
Jul 13, 2021 (view filing)4:58 PM ETJul 121 daySaudi Economic & Development Securities Co and 1 other10% OwnerSSale−50.0K$3.25−$162.6K−5.1%922.5K after2 lots
Aug 20, 2021 (view filing)Aug 182 daysIger YoniVP, RA/QA/Clinical AffairsPPurchase+5.18K$1.94+$10.1KNew position5.18K after
Nov 18, 2021 (view filing)Nov 171 daySerafino DomenicChief Executive OfficerPPurchase+15.5K$1.60+$24.8K+1.9%814.3K after
Nov 19, 2021 (view filing)Nov 19Same daySerafino DomenicChief Executive OfficerPPurchase+17.0K$1.48+$25.2K+2.1%831.3K after
Dec 1, 2021 (view filing)5:29 PM ETDec 1Same daySerafino DomenicChief Executive OfficerPPurchase+37.5K$1.32+$49.6K+4.5%868.8K after
Dec 6, 2021 (view filing)Dec 33 daysPortaro RossPresident Global SalesPPurchase+30.0K$1.35+$40.5KNew position30.0K after
Dec 17, 2021 (view filing)Dec 152 daysBarry Richard ScottDirector, 10% OwnerPPurchase+3.92M$1.25+$4.90M+31.6%16.3M after2 lots
Dec 17, 2021 (view filing)Dec 152 daysKong GarhengDirector, 10% OwnerPPurchase+1.60M$1.25+$2.00M+30.8%6.80M after
Dec 17, 2021 (view filing)Dec 152 daysSullivan Keith JDirectorPPurchase+80.0K$1.25+$100.0KNew position80.0K after
Dec 17, 2021 (view filing)5:28 PM ETDec 152 daysHealthQuest Venture Management II, L.L.C. and 1 other10% OwnerPPurchase+1.60M$1.25+$2.00M+30.8%6.80M afterDuplicate filing
Dec 17, 2021 (view filing)9:45 PM ETDec 152 daysEW Healthcare Partners, L.P. and 3 others10% OwnerPPurchase+3.77M$1.25+$4.71M+31.6%15.7M after
Dec 17, 2021 (view filing)9:45 PM ETDec 152 daysEW Healthcare Partners, L.P. and 3 others10% OwnerPPurchase+151.6K$1.25+$189.5K+0.9%16.3M after
Dec 20, 2021 (view filing)Dec 164 daysPortaro RossPresident Global SalesPPurchase+20.0K$1.35+$27.0K+66.7%50.0K after
Mar 28, 2022 (view filing)Mar 253 daysSerafino DomenicChief Executive OfficerPPurchase+50.0K$0.00$0–50.0K afterDerivative
May 17, 2022 (view filing)May 17Same dayPortaro RossPresident Global SalesPPurchase+10.0K$0.85+$8.50K+20.0%60.0K after
May 23, 2022 (view filing)May 203 daysSerafino DomenicChief Executive OfficerPPurchase+65.0K$0.75+$48.8K+7.5%933.8K after
May 26, 2022 (view filing)May 242 daysHollmig Stanley TylerDirectorPPurchase+40.0K$0.64+$25.6KNew position40.0K after
Aug 31, 2022 (view filing)7:03 PM ETAug 30-311 daySerafino DomenicChief Executive OfficerPPurchase+75.0K$0.3337+$25.0K+8.0%1.01M after2 lots
Sep 13, 2022 (view filing)Sep 121 dayGeorgiadis AnnaVP, Global HRPPurchase+12.8K$0.71+$9.08KNew position12.8K after
Sep 19, 2022 (view filing)Sep 163 daysDella Penna DomenicChief Financial OfficerPPurchase+60.0K$0.59+$35.4K+90.0%126.7K after2 lots
Nov 22, 2022 (view filing)Nov 184 daysBarry Richard ScottDirector, 10% OwnerPPurchase+15.0M$0.20+$3.00M–58.0K afterDerivative2 lots
Nov 22, 2022 (view filing)Nov 184 daysKong GarhengDirector, 10% OwnerPPurchase+3.35M$0.20+$670.0K–335.0K afterDerivative
Nov 22, 2022 (view filing)3:56 PM ETNov 184 daysHealthQuest Venture Management II, L.L.C. and 1 other10% OwnerPPurchase+3.35M$0.20+$670.0K–335.0K afterDerivativeDuplicate filing
Nov 22, 2022 (view filing)5:03 PM ETNov 184 daysDe Silva RajivOfficerPPurchase+1.25M$0.20+$250.0KNew position1.25M after
Nov 22, 2022 (view filing)5:05 PM ETNov 184 daysVarghese Hemanth JacobPresident/Chief Bus. OfficerPPurchase+250.0K$0.20+$50.0KNew position250.0K after
Nov 22, 2022 (view filing)5:07 PM ETNov 184 daysHollmig Stanley TylerDirectorPPurchase+250.0K$0.20+$50.0K+625.0%290.0K after
Nov 22, 2022 (view filing)5:16 PM ETNov 211 dayPortaro RossPresident Global SalesPPurchase+60.0K$0.22+$13.2K+100.0%120.0K after
Nov 22, 2022 (view filing)8:10 PM ETNov 184 daysEW Healthcare Partners, L.P. and 3 others10% OwnerPPurchase+15.0M$0.20+$3.00M–58.0K afterAmendedDerivative2 lotsDuplicate filing
Nov 25, 2022 (view filing)2:36 PM ETNov 22-253 daysNatale AnthonyDirectorSSale−154.3K$0.2776−$42.8K−17.2%744.4K after3 lots
Nov 30, 2022 (view filing)4:34 PM ETNov 28-292 daysNatale AnthonyDirectorSSale−102.9K$0.2545−$26.2K−13.8%641.5K after2 lots
Mar 28, 2023 (view filing)Mar 244 daysSullivan Keith JDirectorPPurchase+75.0K$0.00$0–75.0K afterDerivative
May 17, 2023 (view filing)11:52 AM ETMay 152 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 2 and 3PPurchase+749.1K$2.67+$2.00M–280.9K afterDerivative
Jul 13, 2023 (view filing)10:53 AM ETJul 121 dayEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 2 and 3PPurchase+1.33M$0.00$0–780.9K afterDerivative
Sep 12, 2023 (view filing)4:28 PM ETSep 84 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 2 and 3PPurchase+779.7K$1.28+$1.00M–1.07M afterDerivative
Oct 6, 2023 (view filing)4:15 PM ETOct 42 daysMadryn Health Partners, LP and 3 others10% OwnerPPurchase+3.44M–––248.8K afterDerivative2 lots
Oct 20, 2023 (view filing)4:10 PM ETOct 20Same dayEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 2 and 3PPurchase+1.34M$1.49+$2.00M–1.58M afterDerivative
Jan 19, 2024 (view filing)4:05 PM ETJan 181 dayEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 2PPurchase+1.60M–––Derivative
May 29, 2024 (view filing)6:58 PM ETMay 245 daysMadryn Health Partners, LP and 3 others10% OwnerPPurchase+57.7M–––577.0K afterDerivative
Jun 12, 2024 (view filing)4:06 PM ETJun 7-115 daysLateMarlin Fund, Limited Partnership and 7 others10% OwnerSSaleCommon Stock, $0.0001 par value per share−489.9K$1.20−$589.9K−56.1%383.3K after7 lots
Sep 30, 2024 (view filing)8:20 PM ETSep 264 daysMadryn Health Partners, LP and 3 others10% OwnerPPurchase+20.4M–––780.6K afterDerivative
Oct 2, 2024 (view filing)Sep 30-Oct 22 daysMasters Michael Willingham10% OwnerSSaleCommon Stock, $0.0001 par value per share−306.1K$0.5877−$179.9K−53.1%270.1K after15 lots
Oct 7, 2024 (view filing)Oct 34 daysMasters Michael Willingham10% OwnerSSaleCommon Stock, $0.0001 par value per share−162.9K$0.53−$86.3K−43.7%209.8K after5 lots
Dec 4, 2024 (view filing)5:43 PM ETDec 31 dayNatale AnthonyDirectorSSale−42.8K$0.3085−$13.2K−100.0%0 after
Apr 2, 2025 (view filing)5:47 PM ETMar 312 daysMadryn Health Partners, LP and 3 others10% OwnerPPurchase+3.51M–––1.16M afterDerivative2 lots
Jul 2, 2025 (view filing)7:27 PM ETJun 302 daysMadryn Health Partners, LP and 3 others10% OwnerPPurchase+3.00M–––1.49M afterDerivative2 lots
Oct 2, 2025 (view filing)7:23 PM ETSep 302 daysMadryn Asset Management, LP and 2 others10% OwnerPPurchase+4.96M–––2.03M afterDerivative
Mar 27, 2026 (view filing)4:05 PM ETMar 261 dayEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 3, 5, 7 and 8SSale−668.7K–––Derivative3 lots